OVERVIEW

This CE course for Nurse Practitioners (APRN/NP) offers an in-depth exploration of the most noteworthy pharmacological advances with newly approved drugs in 2024. As the therapeutic landscape rapidly evolves, staying current with innovative medications is essential for optimal patient care. This activity focuses on breakthrough drugs including Zelsuvmi, Alhemo, Alyftrek, Tryngolza, Ensacove, Crenessity, Unloxcyt, Bizengri, Iomervu, Rapiblyk, Attruby, Ziihra, Revuforj, and Orlynvah. Participants will learn about the mechanism of action, clinical indications, dosage protocols, administration routes, contraindications, and potential adverse effects of each medication.

This course is designed to enable nurse practitioners to incorporate these therapies into their clinical decision-making confidently. Emphasis is placed on patient-specific prescribing strategies, monitoring requirements, safety considerations, and managing side effects. By understanding how to integrate these new medications into treatment plans, nurse practitioners will be empowered to address unmet medical needs, optimize patient outcomes, and make meaningful contributions to advancing healthcare delivery. The course equips clinicians to navigate the complexities of rapidly evolving drug innovations in specialized disease states.

Educational Objectives

  • Analyze the indications, mechanisms of action, and usage guidelines for newly approved drugs in 2024.
  • Evaluate dosage regimens, administration methods, and contraindications to optimize safety and outcomes.
  • Recognize and manage potential adverse reactions, monitoring parameters, and risk mitigation strategies.
  • Apply these therapies to appropriate patient populations with tailored clinical decision-making.
  • Integrate new pharmacotherapies into practice to meet unmet needs in specialized disease states.

Who Should Do This Course

This course is intended for Nurse Practitioners (NPs) and Advanced Practice Registered Nurses (APRNs) who are seeking to meet their state-required CE credit requirements in the area of Pharmacotherapeutics or Pharmacology. It fulfills state-mandated requirements for license renewal in:

  • Pharmacotherapeutics: Hawaii, Louisiana, Oklahoma, West Virginia, Connecticut, Arkansas, Illinois, Nebraska, South Carolina, Texas, Washington, Wisconsin
  • Pharmacology: Alabama, Indiana

Did You Know?

  • More than 50 novel drugs have been approved by the FDA in 2024, marking one of the most innovative years in drug development.
  • Pharmacotherapeutics continues to be among the most mandated CE topics for NP license renewal across U.S. states.
  • Precision prescribing based on newly approved therapies improves patient adherence by up to 35% (Source: NEJM, 2023).
  • Many of the newly approved drugs in 2024 are first-in-class therapies offering solutions for previously untreatable conditions.
  • Clinical knowledge of dosing and risk mitigation strategies significantly reduces adverse drug reactions in NP-led practices.
Credits

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 1 contact hour.

Release Date: January  6, 2025
Expiration Date: December 31, 2027

  • 1 Contact Hours
  • TARGET AUDIENCE

    NursingNursesNurse Practitioners

    SPECIALITIES

    Family MedicinePediatricsPsychiatric NursingMental health NurseOncology NursingCardiovascular NursingCritical care NursingEndocrinology NurseNursingPharmacologyPharmacotherapyPharmacy and Medicine

    TERMS & CONDITIONS

    Disclosure Statement
    eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content. 

    All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations. 

    Disclaimer Statement 
    The content, views, and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of eMedEd, Inc. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that the FDA does not indicate in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

    If you have questions about continuing education credit or certificates related to this course, please contact us via email at contact@emeded.org

    Questions about the content, please contact eMedEd, Inc. via email at contact@emeded.org

    Copyright © 2024 eMedEd, Inc.  All rights reserved.  This material may not be reproduced, displayed, modified, or distributed without the express prior written permission of the copyright holder.

    REFUND, CANCELLATION POLICY & DISCLAIMER

    Refunds are subject to the following terms:

    • Eligibility: You may request a refund within 7 days of order confirmation only if none of the courses have been started (i.e., no course progress or completion has occurred).
    • Deductions: Refunds will be processed after deducting applicable online transaction charges.
    • Ineligibility: If any course in the bundle or individual course has been accessed or started, no refund will be issued, even within the 7-day window.
    • Course Expiry & Access: All purchased courses and bundles are accessible for the duration mentioned at the time of purchase. Unused access or non-completion does not qualify for a refund outside the eligible window.


    To request a refund, please email support@emedevents.com with your order details and reason for cancellation.

    DISCLAIMER

    eMedEvents neither represents any State Medical Board nor claims to provide any online course on behalf of the State Medical Board. Subscribing to any of our CME/CE online courses is entirely at the user's discretion, and they should verify with their State Medical Board for their current re-licensure requirements.

    RELATED ONLINE COURSES

    3 Hours
    ...
    More actions

    Webcast

    Chronic Diseases
    12 CME Hours
    More actions
    US$695
    By Provider Practice Essentials...

    Webcast

    State required course for Illinois ...
    70 CME/CE
    More actions
    US$125